Cargando…
Overcoming phenotypic switching: targeting protein-protein interactions in cancer
Alternative protein-protein interactions (PPIs) arising from mutations or post-translational modifications (PTMs), termed phenotypic switching (PS), are critical for the transmission of alternative pathogenic signals and are particularly significant in cancer. In recent years, PPIs have emerged as p...
Autores principales: | Ladias, Christos, Papakotoulas, Pavlos, Papaioannou, Maria, Papanikolaou, Nikolaos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651353/ https://www.ncbi.nlm.nih.gov/pubmed/38023990 http://dx.doi.org/10.37349/etat.2023.00181 |
Ejemplares similares
-
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
por: Laraia, Luca, et al.
Publicado: (2015) -
Strategies towards Targeting Gαi/s Proteins: Scanning of Protein‐Protein Interaction Sites To Overcome Inaccessibility
por: Nubbemeyer, Britta, et al.
Publicado: (2021) -
Long-Term Treatment with Erlotinib for EGFR Wild-Type Non-Small Cell Lung Cancer: A Case Report
por: Polychronidou, Genovefa, et al.
Publicado: (2013) -
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
por: Moscvin, Maria, et al.
Publicado: (2021) -
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
por: Rathore, Rama, et al.
Publicado: (2017)